Login

Ensuring Quality Medicines:

 Bioequivalence Study, Monograph Testing, and Post Marketing Surveillance ONLINE EVALUATION FORM

Unilab Event

Thank you for joining our event. Your honest feedback on the program will help us in assessing the quality of our services and improve succeeding sessions.


DATA PRIVACY NOTICE:

Why do we collect and use your data?

Privacy notice in compliance with RA 10173 Data Privacy Act of 2012:

By voluntarily accomplishing this form, the participant consents to the use and processing of the information collected via this Google Form. This information will be used primarily for communication purposes between you and Global Institute for Professional Development and Excellence (GIPDEX) and will not be shared with outside parties, except where applicable, for the fulfillment of requirements with government offices.

Access our Data Privacy Notice: https://gipdex.com/privacy-policy/

Confirmation of Information Provided(Required)
Data Privacy Consent(Required)
Are you a licensed physician, pharmacist, chemist, chemical technician, chemical engineer, or nurse?(Required)
Name(Required)
DD slash MM slash YYYY
What is your registered profession?(Required)

By submitting this form, you confirm that the name used in this form is the same as the name registered with the PRC. Please make sure the name was entered with the caps lock OFF. The organizing committee will not be held responsible for errors occurring due to incorrect entries.

The supervisor should regularly self-inspect information gathering and operational procedure during the post-marketing surveillance.(Required)
Submission of Bioequivalence (in vivo) Studies is required for products containing what BCS Classes 2 and 3 of API/s.(Required)
It is considered rapidly dissolving when at least 85% of the API is released/dissolved from the comparator and reference drugs within 30 minutes.(Required)
If two products are pharmaceutical equivalents, then they can already be considered therapeutic equivalents.(Required)
Bioequivalence (BE) testing centers/facilities are inspected in compliance with GCP and GLP standards/guidelines.(Required)
Which of the following is not a component of an in vivo bioequivalence study?(Required)
Which of these statements is always true for generic medicinal products?(Required)
Which of the following is true for post-marketing surveillance?(Required)
A national registry was conducted on the different drugs for hypertension. Results showed that the new drug, OxyBP, has several safety issues among the elderly. What type of post-marketing surveillance is this?(Required)
Drugs can be eliminated through the:(Required)
Which of the following is considered as a primary reference standard:(Required)
Given the following drug product formulation in the box packaging: “Each vial contains: Omeprazole (as sodium) USP…… 40mg”, what is the correct interpretation of the drug product formulation?(Required)
The following are important factors affecting potency of reference standards except one:(Required)

Program Evaluation

The objectives of the program were clearly defined and met(Required)
The session topics were timely and appropriate(Required)
The session topics were relevant and applicable to my profession(Required)
The date and time of the event was convenient for me(Required)
The time allotted for each speaker was sufficient(Required)
The time provided for the entire program was sufficient and efficiently managed(Required)
The program host was able to facilitate the flow of the program seamlessly and efficiently(Required)

Venue / Facilities

The venue was clean with good lighting and ventilation(Required)
The setup of the venue was conducive to learning(Required)
The venue was readily accessible and easy to find(Required)
The audiovisuals were clear and easy to understand(Required)
The food provided was sufficient and acceptable(Required)

Organizing Committee

The registration process was simple and easy to follow(Required)
The materials provided were sufficient and distributed in a timely manner(Required)
The members of the organizing committee were responsive to the needs of the participants(Required)
The members of the organizing committee were timely in responding to the needs of the participants(Required)
The event organizer effectively publicized the event to all relevant stakeholders through the appropriate platforms (e.g. emails, Facebook, LinkedIn, CEDRES website, etc.)(Required)
The event organizer requested a registration fee that was justified by the quality of service provided(Required)
Please select your reasons for attending a seminar (select all that apply)(Required)

Speaker: Mr. Willison John E. De Luna, RPh

TOPIC: Regulatory Updates on Biowaiver and Bioequivalence Requirements

The speaker was able to deliver the topic in a manner that facilitated learning(Required)
The speaker was able to inspire movement towards achieving the high quality of medicine(Required)
The speaker was knowledgeable in his/her respective fields(Required)
The speaker was able to stimulate interests and enhance learning(Required)
The flow of discussion was well-executed and was not difficult to follow(Required)
The speaker was able to meet the objectives for his/her session(Required)

Speaker: Dr. Benjamin G. Co, MD, FPPS, FPSECP

TOPIC: Bioequivalence as the Gold Standard

The speaker was able to deliver the topic in a manner that facilitated learning(Required)
The speaker was able to inspire movement towards achieving the high quality of medicine(Required)
The speaker was knowledgeable in his/her respective fields(Required)
The speaker was able to stimulate interests and enhance learning(Required)
The flow of discussion was well-executed and was not difficult to follow(Required)
The speaker was able to meet the objectives for his/her session(Required)

Speaker: Mr. Salvador A. De Guzman Jr., RCh

TOPIC: Importance of Traceable and Reliable Reference Standards in Monograph Tests and Assays

The speaker was able to deliver the topic in a manner that facilitated learning(Required)
The speaker was able to inspire movement towards achieving the high quality of medicine(Required)
The speaker was knowledgeable in his/her respective fields(Required)
The speaker was able to stimulate interests and enhance learning(Required)
The flow of discussion was well-executed and was not difficult to follow(Required)
The speaker was able to meet the objectives for his/her session(Required)

Speaker: Dr. Raymond V. Oliva, MD, MBA, FPCP

TOPIC: Conducting Post-Marketing Surveillance

The speaker was able to deliver the topic in a manner that facilitated learning(Required)
The speaker was able to inspire movement towards achieving the high quality of medicine(Required)
The speaker was knowledgeable in his/her respective fields(Required)
The speaker was able to stimulate interests and enhance learning(Required)
The flow of discussion was well-executed and was not difficult to follow(Required)
The speaker was able to meet the objectives for his/her session(Required)
Should we host another event of a similar nature, would you be interested in participating?(Required)
Would you like to receive news and updates on GIPDEX programs in your email?(Required)
Would you like to receive news and updates on CEDRES programs in your email?(Required)

MORE QUESTIONS?

CONTACT US

Follow us

Facebook Instagram

QUICK LINKS

COMPANY

CONTACT

Unit 1105, The Centerpoint Building, Julia Vargas Avenue corner Garnet Street, Ortigas Center, Pasig City

info@gipdex.com